Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 par value per share
-
Shares outstanding
-
73.8M
-
Number of holders
-
70
-
Total 13F shares, excl. options
-
10.2M
-
Shares change
-
-6.24K
-
Total reported value, excl. options
-
$383M
-
Value change
-
-$2.36M
-
Put/Call ratio
-
0
-
Number of buys
-
31
-
Number of sells
-
-31
-
Price
-
$37.62
Significant Holders of RELMADA THERAPEUTICS, INC. - Common Stock, par value $0.001 par value per share (RLMD) as of Q3 2020
92 filings reported holding RLMD - RELMADA THERAPEUTICS, INC. - Common Stock, par value $0.001 par value per share as of Q3 2020.
RELMADA THERAPEUTICS, INC. - Common Stock, par value $0.001 par value per share (RLMD) has 70 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.2M shares
of 73.8M outstanding shares and own 13.79% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (1.51M shares), Avoro Capital Advisors LLC (1.5M shares), BlackRock Inc. (1.21M shares), RA CAPITAL MANAGEMENT, L.P. (781K shares), VANGUARD GROUP INC (673K shares), VR Adviser, LLC (668K shares), TANG CAPITAL MANAGEMENT LLC (500K shares), PARSONS CAPITAL MANAGEMENT INC/RI (455K shares), STATE STREET CORP (302K shares), and BOXER CAPITAL, LLC (300K shares).
This table shows the top 70 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.